Can Vyvanse help with narcolepsy?
Nuvigil (armodafinil) and Vyvanse (lisdexamfetamine dimesylate) are used to treat narcolepsy. Nuvigil is also used to treat excessive sleepiness caused by sleep apnea or shift work sleep disorder. Vyvanse is used off-label to treat narcolepsy.
Is Vyvanse FDA approved for narcolepsy?
FDA approved indications: Attention Deficit Hyperactivity Disorder and Narcolepsy (1-12). Vyvanse is also indicated for Moderate to Severe Binge Eating Disorder (6). Limitation of Use: Vyvanse is not indicated for weight loss.
Does Vyvanse help with daytime sleepiness?
UK drugmaker Shire is reviewing the development pathway for its attention-deficit hyperactivity disorder drug Vyvanse after the drug showed potential in a new indication – the treatment of excessive daytime sleepiness (EDS).
Is Vyvanse worse than Adderall?
This means that the side effects from Vyvanse are considered to be less harsh. These drugs are considered to be potential drugs of abuse; however, because Vyvanse is a prodrug and takes longer to metabolize in the system than Adderall, it is considered to have a lower risk of abuse.
Can you substitute Vyvanse for Adderall?
Because both drugs contain amphetamines, they work in a similar way. Studies have shown that Vyvanse is just as effective as Adderall, and side effects are similar.
Why am I so tired even on Vyvanse?
A few hours after a person stops taking Vyvanse, it starts to leave their system, which leads to a chemical imbalance in the brain. Because Vyvanse is a stimulant, when the drug leaves the body, some people may feel effects that are opposite to stimulation, such as fatigue and irritability.
Is Vyvanse used for extreme fatigue?
Young, MD, medical director of the Rochester Center for Behavioral Medicine in Rochester Hills, Mich., examined whether lisdexamfetamine dimesylate (LDX; Vyvanse, Shire Development) was effective in the treatment of adults diagnosed with chronic fatigue syndrome (CFS) using a double-blind, placebo-controlled study.
Is Vyvanse good long term?
NEW YORK – Lisdexamfetamine dimesylate (LDX) is effective over the long term in treating attention-deficit/hyperactivity disorder (ADHD) in children and adolescents, according to a new phase 3 extension study.
